NEW YORK (GenomeWeb) – Agilent Technologies today announced that it will provide access to its bioanalytical instruments to National University of Singapore Yong Loo Lin School of Medicine (NUS Medicine) for use in a study of patient responses to cardiovascular medicines.

Under the terms of their arrangement, the school's department of medicine will have access to Agilent's proof-of-concept laboratory in Singapore, which includes its 6550 iFunnel quadrupole time-of-flight liquid chromatography mass spectrometry system, as well as its Capillary Electrophoresis System model 7100.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

The London School of Economics' Daniele Fanelli argues at the Proceedings of the National Academy of Sciences that the reproducibility crisis in science isn't as dire as some say.

A team of researchers in Portugal has examined the genomic basis for racing pigeons' athleticism and navigational skills, finding it's likely polygenic.

Wired reports that diagnostic firms continue to seek, post-Theranos, the ability to diagnose diseases from small amounts of blood.

In Science this week: analysis of DNA from ancient North Africans, and more.